Pharming Group NV (PHAR)
12.28
-0.31
(-2.46%)
USD |
NASDAQ |
Jun 10, 16:00
Pharming Group Shareholders Equity (Quarterly) : 268.96M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 268.96M |
| December 31, 2025 | 277.10M |
| September 30, 2025 | 264.64M |
| June 30, 2025 | 227.33M |
| March 31, 2025 | 214.00M |
| December 31, 2024 | 221.06M |
| September 30, 2024 | 225.79M |
| June 30, 2024 | 209.85M |
| March 31, 2024 | 205.94M |
| December 31, 2023 | 218.78M |
| September 30, 2023 | 209.94M |
| June 30, 2023 | 200.37M |
| March 31, 2023 | 199.34M |
| December 31, 2022 | 204.64M |
| September 30, 2022 | 200.25M |
| June 30, 2022 | 199.67M |
| March 31, 2022 | 194.02M |
| December 31, 2021 | 192.92M |
| September 30, 2021 | 193.55M |
| June 30, 2021 | 198.07M |
| March 31, 2021 | 186.36M |
| December 31, 2020 | 182.77M |
| September 30, 2020 | 159.78M |
| June 30, 2020 | 143.28M |
| March 31, 2020 | 126.86M |
| Date | Value |
|---|---|
| December 31, 2019 | 117.50M |
| September 30, 2019 | 98.64M |
| June 30, 2019 | 88.25M |
| March 31, 2019 | 77.55M |
| December 31, 2018 | 70.59M |
| September 30, 2018 | 55.95M |
| June 30, 2018 | 47.48M |
| March 31, 2018 | 38.87M |
| December 31, 2017 | 22.58M |
| September 30, 2017 | 7.344M |
| June 30, 2017 | 7.715M |
| March 31, 2017 | 30.95M |
| December 31, 2016 | 28.97M |
| September 30, 2016 | 16.84M |
| June 30, 2016 | 20.17M |
| March 31, 2016 | 23.97M |
| December 31, 2015 | 25.90M |
| September 30, 2015 | 28.55M |
| June 30, 2015 | 31.08M |
| March 31, 2015 | 31.44M |
| December 31, 2014 | 36.11M |
| September 30, 2014 | 20.06M |
| June 30, 2014 | 16.69M |
| March 31, 2014 | 9.801M |
| December 31, 2013 | 6.904M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ProQR Therapeutics NV | 43.32M |
| NewAmsterdam Pharma Co. NV | 665.22M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alkermes Plc | 1.752B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 489.36M |
| Total Liabilities (Quarterly) | 220.41M |
| Debt to Equity Ratio | 0.4321 |
| Current Ratio | 2.630 |
| Net Debt Paydown Yield | -0.07% |